XSHE
000955
Market cap346mUSD
Jun 03, Last price
4.63CNY
1D
-0.64%
1Q
0.87%
Jan 2017
-39.56%
Name
Xinlong Holding Group Company Ltd
Chart & Performance
Profile
Xinglong Holding (Group) Company Ltd. engages in the research, development, production, processing, and sale of spunlace, melt-spun, and other nonwoven materials for medical and health protection, household cleaning, personal care, beauty and makeup, tourism, etc. The company is also involved in the provision of non-woven terminal products; distribution and sale of drugs and medical services; and trading of petroleum, natural rubber, and other products. It exports its products. Xinglong Holding (Group) Company Ltd. was founded in 1993 and is based in Haikou, the People's Republic of China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | ||||||||||
Revenues | 522,978 -11.53% | 591,118 -29.42% | 837,502 -17.62% | |||||||
Cost of revenue | 497,211 | 580,368 | 818,309 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 25,767 | 10,750 | 19,193 | |||||||
NOPBT Margin | 4.93% | 1.82% | 2.29% | |||||||
Operating Taxes | 43 | 582 | 1,576 | |||||||
Tax Rate | 0.17% | 5.41% | 8.21% | |||||||
NOPAT | 25,724 | 10,168 | 17,617 | |||||||
Net income | ||||||||||
Dividends | (7,068) | |||||||||
Dividend yield | 0.26% | |||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 20,026 | 26,037 | 178,683 | |||||||
Long-term debt | 38,700 | 52,700 | 25,000 | |||||||
Deferred revenue | 8,624 | 12,829 | ||||||||
Other long-term liabilities | 10,639 | 1 | ||||||||
Net debt | (159,474) | (151,057) | (82,308) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 10,011 | 33,501 | 58,568 | |||||||
CAPEX | (6,709) | |||||||||
Cash from investing activities | 117,141 | 100,393 | ||||||||
Cash from financing activities | (92,768) | |||||||||
FCF | 15,966 | 130,577 | 173,631 | |||||||
Balance | ||||||||||
Cash | 218,200 | 254,040 | 285,992 | |||||||
Long term investments | (24,247) | |||||||||
Excess cash | 192,051 | 200,238 | 244,116 | |||||||
Stockholders' equity | 610,176 | 294,838 | 665,604 | |||||||
Invested Capital | 595,171 | 627,912 | 743,173 | |||||||
ROIC | 4.21% | 1.48% | 2.07% | |||||||
ROCE | 3.27% | 1.30% | 1.94% | |||||||
EV | ||||||||||
Common stock shares outstanding | 538,395 | 538,395 | 538,395 | |||||||
Price | 4.14 -18.50% | 5.08 1.80% | 4.99 1.42% | |||||||
Market cap | 2,228,955 -18.50% | 2,735,047 1.80% | 2,686,591 1.42% | |||||||
EV | 2,141,262 | 2,658,059 | 2,685,436 | |||||||
EBITDA | 51,928 | 37,654 | 54,173 | |||||||
EV/EBITDA | 41.23 | 70.59 | 49.57 | |||||||
Interest | 4,334 | 7,238 | 12,215 | |||||||
Interest/NOPBT | 16.82% | 67.33% | 63.64% |